Provexis plc (PXS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.307x

Based on the latest financial reports, Provexis plc (PXS) has a cash flow conversion efficiency ratio of -0.307x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-187.53K ≈ $-22.82 USD) by net assets (GBX610.89K ≈ $74.33 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PXS equity to assets ratio to measure how much of total assets are equity-financed.

Provexis plc - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Provexis plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Provexis plc (PXS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Provexis plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Provexis plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mitra Komunikasi Nusantara Tbk PT JK:MKNT	-0.463x
Sanco Industries Limited NSE:SANCO	0.025x
Dewhurst plc LSE:DWHA	0.062x
Subsea 7 SA LSE:0OGK	-0.030x
Abingdon Health Plc LSE:ABDX	-0.204x
Kavango Resources PLC LSE:KAV	-0.160x
Desarrolladora Homex S.A.B. de C.V MX:HOMEX	-0.024x
GO.D.M Investments Ltd TA:GODM	-0.255x

Annual Cash Flow Conversion Efficiency for Provexis plc (2004–2025)

The table below shows the annual cash flow conversion efficiency of Provexis plc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Provexis plc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX763.82K ≈ $92.93	GBX-340.83K ≈ $-41.47	-0.446x	+55.59%
2024-03-31	GBX190.59K ≈ $23.19	GBX-191.50K ≈ $-23.30	-1.005x	-27.11%
2023-03-31	GBX657.65K ≈ $80.02	GBX-519.85K ≈ $-63.25	-0.790x	-258.73%
2022-03-31	GBX969.08K ≈ $117.91	GBX-213.54K ≈ $-25.98	-0.220x	+3.97%
2021-03-31	GBX1.14 Million ≈ $138.97	GBX-262.07K ≈ $-31.89	-0.229x	+78.15%
2020-03-31	GBX318.68K ≈ $38.77	GBX-334.64K ≈ $-40.72	-1.050x	+7.33%
2019-03-31	GBX338.89K ≈ $41.23	GBX-384.01K ≈ $-46.72	-1.133x	-2.77%
2018-03-31	GBX329.26K ≈ $40.06	GBX-363.05K ≈ $-44.17	-1.103x	+93.62%
2017-03-31	GBX24.89K ≈ $3.03	GBX-430.30K ≈ $-52.36	-17.291x	-574.63%
2016-03-31	GBX142.84K ≈ $17.38	GBX-366.10K ≈ $-44.54	-2.563x	-55.70%
2015-03-31	GBX245.90K ≈ $29.92	GBX-404.78K ≈ $-49.25	-1.646x	-53.62%
2014-03-31	GBX535.08K ≈ $65.10	GBX-573.34K ≈ $-69.76	-1.072x	-491.02%
2013-03-31	GBX7.91 Million ≈ $961.92	GBX-1.43 Million ≈ $-174.40	-0.181x	+5.42%
2012-03-31	GBX11.30 Million ≈ $1.37K	GBX-2.17 Million ≈ $-263.54	-0.192x	-7.20%
2011-03-31	GBX11.48 Million ≈ $1.40K	GBX-2.05 Million ≈ $-249.79	-0.179x	-31.87%
2010-03-31	GBX11.06 Million ≈ $1.35K	GBX-1.50 Million ≈ $-182.51	-0.136x	+44.43%
2009-03-31	GBX5.53 Million ≈ $673.08	GBX-1.35 Million ≈ $-164.26	-0.244x	-24.48%
2008-03-31	GBX7.58 Million ≈ $922.88	GBX-1.49 Million ≈ $-180.92	-0.196x	+40.54%
2007-03-31	GBX6.61 Million ≈ $804.12	GBX-2.18 Million ≈ $-265.12	-0.330x	-6.14%
2006-03-31	GBX8.85 Million ≈ $1.08K	GBX-2.75 Million ≈ $-334.47	-0.311x	+87.48%
2005-03-31	GBX510.00K ≈ $62.05	GBX-1.26 Million ≈ $-153.91	-2.480x	+64.89%
2004-03-31	GBX108.00K ≈ $13.14	GBX-763.00K ≈ $-92.84	-7.065x	--

About Provexis plc

LSE:PXS UK Drug Manufacturers - Specialty & Generic

Market Cap

$321.11K

GBX2.64 Billion GBX

Market Cap Rank

#31069 Global

#975 in UK

Share Price

GBX1.13

Change (1 day)

+2.27%

52-Week Range

GBX0.56 - GBX1.51

All Time High

GBX1.51